BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31712778)

  • 1. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.
    Kamijo H; Miyagaki T; Takahashi-Shishido N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
    Leukemia; 2020 Mar; 34(3):845-856. PubMed ID: 31712778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
    Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
    Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
    Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
    Front Immunol; 2019; 10():1268. PubMed ID: 31214201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell Lymphoma.
    Han Z; Wu X; Qin H; Yuan YC; Zain J; Smith DL; Akilov OE; Rosen ST; Feng M; Querfeld C
    J Invest Dermatol; 2023 Aug; 143(8):1569-1578.e5. PubMed ID: 36863449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
    Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
    J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
    Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
    Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells.
    Bissinger R; Petkova-Kirova P; Mykhailova O; Oldenborg PA; Novikova E; Donkor DA; Dietz T; Bhuyan AAM; Sheffield WP; Grau M; Artunc F; Kaestner L; Acker JP; Qadri SM
    Cell Commun Signal; 2020 Sep; 18(1):155. PubMed ID: 32948210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
    Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
    Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.
    Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Kagami S; Asano Y; Tada Y; Kadono T; Sato S
    Acta Derm Venereol; 2013 Mar; 93(2):144-9. PubMed ID: 22948508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34
    Jahan J; Monte de Oca I; Meissner B; Joshi S; Maghrabi A; Quiroz-Olvera J; Lopez-Yang C; Bartelmez SH; Garcia C; Jarajapu YP
    Eur J Pharmacol; 2022 Apr; 920():174842. PubMed ID: 35217004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
    Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment.
    Nakajima R; Miyagaki T; Hirakawa M; Oka T; Takahashi N; Suga H; Yoshizaki A; Fujita H; Asano Y; Sugaya M; Sato S
    Br J Dermatol; 2018 Jun; 178(6):1373-1382. PubMed ID: 29238954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.
    Kukreja A; Radfar S; Sun BH; Insogna K; Dhodapkar MV
    Blood; 2009 Oct; 114(16):3413-21. PubMed ID: 19661269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Role of TSP-1-CD47 in ROS-mediated Pulmonary Fibrosis Induced by Paraquat].
    Gao W; Xie XS
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Sep; 36(9):653-661. PubMed ID: 30419666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.